START Midwest /ID# 252359 — Grand Rapids, Michigan

START Midwest /ID# 252359 is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

START Midwest /ID# 252359 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Midwest /ID# 252359?

START Midwest /ID# 252359 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Midwest /ID# 252359 conducted?

START Midwest /ID# 252359 has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies.

Is START Midwest /ID# 252359 accredited by Crixeo Health?

START Midwest /ID# 252359 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Midwest /ID# 252359?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.